Status:
COMPLETED
The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Diabetes
Cardiovascular Risk
Eligibility:
FEMALE
46-70 years
Phase:
NA
Brief Summary
The investigators propose to perform a double-blind, randomized placebo-controlled trial to examine the hypothesis that soy protein with isoflavones could improve glycemic control, insulin sensitivity...
Eligibility Criteria
Inclusion
- Hong Kong Chinese menopausal women aged 46-70 years with prediabetes or early untreated diabetes
Exclusion
- Women with breast, ovary or other cancers in recent 5-year
- Severe renal or liver dysfunction
- Women with androgen excess
- Smokers
- Current use or recent (3-month)use of any drug or treatment for glycemic control, lipid improvement, weight reduction; Subjects with known soy or milk allergy.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00856882
Start Date
October 1 2007
Last Update
March 6 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.